The American Diabetes Association in Collaboration with Pri-Med

While the diabetes epidemic shows no signs of slowing down, behind the statistics are patients who need your help now.

The American Diabetes Association has partnered with Pri-Med to create an all-new CME curriculum on diabetes. Current Concepts in Diabetes can help busy clinicians stay up-to-date on emerging clinical insights. The seven-session program, taught by distinguished clinician-presenters, will examine recent findings on:

• Data from Recent Clinical Trials
• Glucose Management
• Diabetes-related complications

Earn up to 7.5 complimentary AMA PRA Category 1 Credit(s)™ or AANP contact hours of continuing education at no cost. For more information or to register, you can also call (866) 263-7806.

2010 Sessions and Workshops Include*:

Diabetes Mellitus: An American Epidemic

• Assess the reasons for the marked increases in the incidence and prevalence of type 2 diabetes (T2DM) in the US
• Identify the components of cardiometabolic risk and their relationship to the development and progression of T2DM
• Apply evidence-based strategies to the management of the “ABCs of Diabetes”

Identifying and Managing the Patient at Risk for Diabetes

• Evaluate and apply the revised diagnostic criteria for prediabetes and diabetes in order to improve competencies in identifying patients with diabetes as well as those who are at high risk for its development
• Implement strategies for preventing or delaying the onset of diabetes in patients at risk

Maximizing Therapeutic Lifestyle Changes and First-line Oral Agents to Manage Diabetic Hyperglycemia

• Strategize effective solutions for helping patients with diabetes affect therapeutic lifestyle changes, with a focus on underserved patient populations
• Review clinical practice considerations for selecting, initiating, and titrating oral antihyperglycemic therapies

Getting Your Patient to Goal: Oral Antihyperglycemic Combinations and Incretin-based Therapies

• Define the benefits and risks of various combinations of oral antidiabetic drug (OAD) therapies in order to select and optimize appropriate treatments for diabetic patients not at target goal with initial regimens
• Assess the benefits and risks of incretin-based therapies, and create practice strategies for implementation in patient-specific scenarios to improve glycemic levels according to guidelines

Preventing and Managing Diabetes-related Complications

• Maximize the prevention of diabetes-related cardiovascular complications through intensive management of hypertension and abnormal lipid parameters
• Apply strategies for early recognition and appropriate management of common diabetes-related comorbidities and complications, including renal impairment, nonalcoholic fatty liver disease and diabetic peripheral neuropathy

*Subject to change.